252. Preclinical Safety and Toxicity Assessment of Stathmin 1 Bifunctional shRNA Formulation Following a Single Intravenous Injection in Rats

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)37693-6
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV